Filing Details
- Accession Number:
- 0001104659-16-131001
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-07-05 16:15:44
- Reporting Period:
- 2016-06-30
- Filing Date:
- 2016-07-05
- Accepted Time:
- 2016-07-05 16:15:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1492674 | T2 Biosystems Inc. | TTOO | Surgical & Medical Instruments & Apparatus (3841) | 204827488 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1667658 | Rahul Dhanda | 101 Hartwell Avenue Lexington MA 02421 | Svp Of Corporate Development | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-06-30 | 3,589 | $2.45 | 3,589 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-06-30 | 3,589 | $8.16 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2016-06-30 | 3,589 | $0.00 | 3,589 | $2.45 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
31,705 | 2016-01-17 | 2022-01-17 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 5, 2016.
- The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $8.15 to $8.24. The reporting person undertakes to provide upon request the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.